Manoj S Nair (Manoj Nair)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 30

Top Topics

Respiratory Syndrome Coronavirus

Monoclonal Antibody

Top Venues

Nature communications

bioRxiv : the preprint server for biology

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Manoj S Nair, Maria I Luck, Yaoxing Huang, Yosef Sabo, David D Ho
Persistence of an infectious form of SARS-CoV-2 post protease inhibitor treatment of permissive cells in vitro. The Journal of infectious diseases (2024)
Ramsey Bekdash, Kazushige Yoshida, Manoj S Nair, Lauren Qiu, Johnathan Ahdout, Hsiang-Yi Tsai, Kunihiro Uryu, Rajesh K Soni, Yaoxing Huang, David D Ho, Masayuki Yazawa
Developing inhibitory peptides against SARS-CoV-2 envelope protein. PLoS biology 22 (3) (2024)
Ramsey Bekdash, Kazushige Yoshida, Manoj S Nair, Lauren Qiu, Johnathan Ahdout, Hsiang-Yi Tsai, Kunihiro Uryu, Rajesh K Soni, Yaoxing Huang, David D Ho, Masayuki Yazawa
Developing inhibitory peptides against SARS-CoV-2 envelope protein. PLoS biology 22 (3) (2024)
Ramsey Bekdash, Kazushige Yoshida, Manoj S Nair, Lauren Qiu, Johnathan Ahdout, Hsiang-Yi Tsai, Kunihiro Uryu, Rajesh K Soni, Yaoxing Huang, David D Ho, Masayuki Yazawa
Developing inhibitory peptides against SARS-CoV-2 envelope protein. PLoS biology 22 (3) (2024)
Manoj S Nair, Maria I Luck, Yaoxing Huang, Yosef Sabo, David D Ho
Persistence of an infectious form of SARS-CoV-2 post protease inhibitor treatment of permissive cells in vitro. The Journal of infectious diseases (2024)
Manoj S Nair, Maria I Luck, Yaoxing Huang, Yosef Sabo, David D Ho
Persistence of an infectious form of SARS-CoV-2 post protease inhibitor treatment of permissive cells in vitro. bioRxiv : the preprint server for biology (2023)
Clare Burn Aschner, Krithika Muthuraman, Iga Kucharska, Hong Cui, Katherine Prieto, Manoj S Nair, Maple Wang, Yaoxing Huang, Natasha Christie-Holmes, Betty Poon, Jessica Lam, Azmiri Sultana, Robert Kozak, Samira Mubareka, John L Rubinstein, Edurne Rujas, Bebhinn Treanor, David D Ho, Arif Jetha, Jean-Philippe Julien
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo. Science translational medicine 15 (697) (2023)
Manoj S Nair, Maria I Luck, Yaoxing Huang, Yosef Sabo, David D Ho
Persistence of an infectious form of SARS-CoV-2 post protease inhibitor treatment of permissive cells in vitro. bioRxiv : the preprint server for biology (2023)
Qian Wang, Yicheng Guo, Liyuan Liu, Logan T Schwanz, Zhiteng Li, Manoj S Nair, Jerren Ho, Richard M Zhang, Sho Iketani, Jian Yu, Yiming Huang, Yiming Qu, Riccardo Valdez, Adam S Lauring, Yaoxing Huang, Aubree Gordon, Harris H Wang, Lihong Liu, David D Ho
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike. Nature (2023)
Moriya Tsuji, Manoj S Nair, Kazuya Masuda, Candace Castagna, Zhenlu Chong, Tamarand L Darling, Kuljeet Seehra, Youngmin Hwang, Ágata Lopes Ribeiro, Geovane Marques Ferreira, Laura Corredor, Jordana Grazziela Alves Coelho-Dos-Reis, Yukiko Tsuji, Munemasa Mori, Adrianus C M Boon, Michael S. Diamond, Yaoxing Huang, David D Ho
An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo. Nature communications 14 (1) (2023)
Manoj S Nair, Maria I Luck, Yaoxing Huang, Yosef Sabo, David D Ho
Persistence of an infectious form of SARS-CoV-2 post protease inhibitor treatment of permissive cells in vitro. bioRxiv : the preprint server for biology (2023)
M Gordon Joyce, Hannah A D King, Ines Elakhal-Naouar, Aslaa Ahmed, Kristina K Peachman, Camila Macedo Cincotta, Caroline Subra, Rita E Chen, Paul V Thomas, Wei-Hung Chen, Rajeshwer S Sankhala, Agnes Hajduczki, Elizabeth J Martinez, Caroline E Peterson, William C Chang, Misook Choe, Clayton Smith, Parker J Lee, Jarrett A Headley, Mekdi G Taddese, Hanne A Elyard, Anthony Cook, Alexander Anderson, Kathryn McGuckin Wuertz, Ming Dong, Isabella Swafford, James Brett Case, Jeffrey R Currier, Kerri G Lal, Sebastian Molnar, Manoj S Nair, Vincent Dussupt, Sharon P Daye, Xiankun Zeng, Erica K Barkei, Hilary M Staples, Kendra J Alfson, Ricardo Carrion, Shelly J Krebs, Dominic Paquin-Proulx, Nicos Karasavva, Victoria R Polonis, Linda L Jagodzinski, Mihret F Amare, Sandhya Vasan, Paul T Scott, Yaoxing Huang, David D Ho, Natalia De Val, Michael S. Diamond, Mark G Lewis, Mangala Rao, Gary R Matyas, Gregory D Gromowski, Sheila A Peel, Nelson L Michael, Diane L Bolton, Kayvon Modjarrad
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates. Science translational medicine 14 (632) (2022)
Sho Iketani, Lihong Liu, Manoj S Nair, Abishek Chandrashekar, Hiroshi Mohri, Maple Wang, Dan H Barouch, Yaoxing Huang, David D Ho
Ad26.COV2.S boosts antibody and T-cell responses following BNT162b2 vaccination. Emerging microbes & infections 10 (1) (2022)
Qian Wang, Yicheng Guo, Sho Iketani, Manoj S Nair, Zhiteng Li, Hiroshi Mohri, Maple Wang, Jian Yu, Anthony D Bowen, Jennifer Y Chang, Jayesh G Shah, Nadia Nguyen, Zhiwei Chen, Kathrine Meyers, Michael T Yin, Magdalena E Sobieszczyk, Zizhang Sheng, Yaoxing Huang, Lihong Liu, David D Ho
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature 608 (7923) (2022)
Lihong Liu, Sho Iketani, Yicheng Guo, Eswar R Reddem, Ryan G Casner, Manoj S Nair, Jian Yu, Jasper Fuk-Woo Chan, Maple Wang, Gabriele Cerutti, Zhiteng Li, Nicholas C Morano, Candace D Castagna, Laura Corredor, Hin Chu, Shuo-Feng Yuan, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Zhiwei Chen, Yang Luo, Marcus Cunningham, Alejandro Chavez, Michael T Yin, David S Perlin, Moriya Tsuji, Kwok-Yung Yuen, Peter D Kwong, Zizhang Sheng, Yaoxing Huang, Lawrence Shapiro, David D Ho
An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses. Science translational medicine 14 (646) (2022)
Hengrui Liu, Sho Iketani, Arie Zask, Nisha Khanizeman, Eva Bednarova, Farhad Forouhar, Brandon Fowler, Seo Jung Hong, Hiroshi Mohri, Manoj S Nair, Yaoxing Huang, Nicholas E S Tay, Sumin Lee, Charles Karan, Samuel J Resnick, Colette Quinn, Wenjing Li, Henry Shion, Xin Xia, Jacob D Daniels, Michelle Bartolo-Cruz, Marcelo Farina, Presha Rajbhandari, Christopher Jurtschenko, Matthew A Lauber, Thomas McDonald, Michael E Stokes, Brett L Hurst, Tomislav Rovis, Alejandro Chavez, David D Ho, Brent R Stockwell
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19. Nature communications 13 (1) (2022)
Marciela M DeGrace, Elodie Ghedin, Matthew B Friemann, Florian Krammer, Alba Grifoni, Arghavan Alisoltani, Galit Alter, Rama Rao Amara, Ralph S Baric, Dan H Barouch, Jesse D Bloom, Louis-Marie Bloyet, Gaston Bonenfant, Adrianus C M Boon, Eli A Boritz, Debbie L Bratt, Traci L Bricker, Liliana Brown, William J Buchser, Juan Manuel Carreño, Liel Cohen-Lavi, Tamarand L Darling, Meredith E Davis-Gardner, Bethany L Dearlove, Han Di, Meike Dittmann, Nicole A Doria-Rose, Daniel C Douek, Christian Drosten, Venkata-Viswanadh Edara, Ali H Ellebedy, Thomas P Fabrizio, Guido Ferrari, Will M Fischer, William C Florence, Ron A M Fouchier, John Franks, Adolfo García-Sastre, Adam Godzik, Ana Silvia Gonzalez-Reiche, Aubree Gordon, Bart L Haagmans, Peter J Halfmann, David D Ho, Michael R Holbrook, Yaoxing Huang, Sarah L James, Lukasz Jaroszewski, Trushar Jeevan, Robert M Johnson, Terry C Jones, Astha Joshi, Yoshihiro Kawaoka, Lisa Kercher, Marion P G Koopmans, Bette T Korber, Eilay Koren, Richard A Koup, Eric B LeGresley, Jacob E Lemieux, Mariel J Liebeskind, Zhuoming Liu, Brandi Livingston, James P Logue, Yang Luo, Adrian B McDermott, Margaret J McElrath, Victoria A Meliopoulos, Vineet D Menachery, David C Montefiori, Barbara Mühlemann, Vincent J Munster, Jenny E Munt, Manoj S Nair, Antonia Netzl, Anna M Niewiadomska, Sijy O'Dell, Andrew S Pekosz, Stanley Perlman, Marjorie C Pontelli, Barry Rockx, Morgane Rolland, Paul W Rothlauf, Sinai Sacharen, Richard H Scheuermann, Stephen D Schmidt, Michael Schotsaert, Stacey Schultz-Cherry, Robert A Seder, Mayya Sedova, Alessandro Sette, Reed S Shabman, Xiaoying Shen, Pei-Yong Shi, Maulik Shukla, Viviana Simon, Spencer Stumpf, Nancy J Sullivan, Larissa B Thackray, James Theiler, Paul Glyndwr Thomas, Sanja Trifkovic, Sina Türeli, Samuel A Turner, Maria A Vakaki, Harm van Bakel, Laura A VanBlargan, Leah R Vincent, Zachary S Wallace, Li Wang, Maple Wang, Pengfei Wang, Wei Wang, Scott C Weaver, Richard John Webby, Carol D Weiss, David E Wentworth, Stuart M Weston, Sean P J Whelan, Bradley M Whitener, Samuel H Wilks, Xuping Xie, Baoling Ying, Hyejin Yoon, Bin Zhou, Tomer Hertz, Derek J Smith, Michael S. Diamond, Diane J Post, Mehul S Suthar
Defining the risk of SARS-CoV-2 variants on immune protection. Nature 605 (7911) (2022)
James A Hay, Stephen M Kissler, Joseph R Fauver, Christina Mack, Caroline G Tai, Radhika M Samant, Sarah Connolly, Deverick J Anderson, Gaurav Khullar, Matthew MacKay, Miral Patel, Shannan Kelly, April Manhertz, Isaac Eiter, Daisy Salgado, Tim Baker, Ben Howard, Joel T Dudley, Christopher E Mason, Manoj S Nair, Yaoxing Huang, John DiFiori, David D Ho, Nathan D Grubaugh, Yonatan Hagai Grad
Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study. eLife 11 (2022)
Hannah A D King, M Gordon Joyce, Ines Lakhal-Naouar, Aslaa Ahmed, Camila Macedo Cincotta, Caroline Subra, Kristina K Peachman, Holly R Hack, Rita E Chen, Paul V Thomas, Wei-Hung Chen, Rajeshwer S Sankhala, Agnes Hajduczki, Elizabeth J Martinez, Caroline E Peterson, William C Chang, Misook Choe, Clayton Smith, Jarrett A Headley, Hanne A Elyard, Anthony Cook, Alexander Anderson, Kathryn McGuckin Wuertz, Ming Dong, Isabella Swafford, James B Case, Jeffrey R Currier, Kerri G Lal, Mihret F Amare, Vincent Dussupt, Sebastian Molnar, Sharon P Daye, Xiankun Zeng, Erica K Barkei, Kendra J Alfson, Hilary M Staples, Ricardo Carrion, Shelly J Krebs, Dominic Paquin-Proulx, Nicos Karasavva, Victoria R Polonis, Linda L Jagodzinski, Sandhya Vasan, Paul T Scott, Yaoxing Huang, Manoj S Nair, David D Ho, Natalia De Val, Michael S Diamond, Mark G Lewis, Mangala Rao, Gary R Matyas, Gregory D Gromowski, Sheila A Peel, Nelson L Michael, Kayvon Modjarrad, Diane L Bolton
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques. Proceedings of the National Academy of Sciences of the United States of America 118 (38) (2021)
Lihong Liu, Sho Iketani, Yicheng Guo, Jasper Fuk-Woo Chan, Maple Wang, Liyuan Liu, Yang Luo, Hin Chu, Yiming Huang, Manoj S Nair, Jian Yu, Kenn K-H Chik, Terrence T-T Yuen, Chaemin Yoon, Kelvin Kai Wang To, Hong-Lin Chen, Michael T Yin, Magdalena E Sobieszczyk, Yaoxing Huang, Harris H Wang, Zizhang Sheng, Kwok-Yung Yuen, David D Ho
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature 602 (7898) (2021)
David D Ho, Pengfei Wang, Lihong Liu, Sho Iketani, Yang Luo, Yicheng Guo, Maple Wang, Jian Yu, Baoshan Zhang, Peter Kwong, Barney Graham, John Mascola, Jennifer Chang, Michael Yin, Magdalena Sobieszczyk, Christos A Kyratsous, Lawrence Shapiro, Zizhang Sheng, Manoj S Nair, Yaoxing Huang
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization. Research square (2021)
Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S Nair, Arie Zask, Yaoxing Huang, Li Xing, Brent R Stockwell, Alejandro Chavez, David D Ho
Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors. Nature communications 12 (1) (2021)
Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S Nair, Arie Zask, Yaoxing Huang, Li Xing, Brent R Stockwell, Alejandro Chavez, David D Ho
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors. Nature communications 12 (1) (2021)
Pengfei Wang, Manoj S Nair, Lihong Liu, Sho Iketani, Yang Luo, Yicheng Guo, Maple Wang, Jian Yu, Baoshan Zhang, Peter D Kwong, Barney S Graham, John R Mascola, Jennifer Y Chang, Michael T Yin, Magdalena Sobieszczyk, Christos A Kyratsous, Lawrence Shapiro, Zizhang Sheng, Yaoxing Huang, David D Ho
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 593 (7857) (2021)
Medini K Annavajhala, Hiroshi Mohri, Pengfei Wang, Manoj S Nair, Jason E Zucker, Zizhang Sheng, Angela Gomez-Simmonds, Anne L Kelley, Maya Tagliavia, Yaoxing Huang, Trevor Bedford, David D Ho, Anne-Catrin Uhlemann
Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York. Nature 597 (7878) (2021)
Jianliang Xu, Kai Xu, Seolkyoung Jung, Andrea Conte, Jenna Lieberman, Frauke Mücksch, Julio Cesar Cetrulo Lorenzi, Solji Park, Fabian Schmidt, Zijun Wang, Yaoxing Huang, Yang Luo, Manoj S Nair, Pengfei Wang, Jonathan E Schulz, Lino Tessarollo, Tatsiana Bylund, Gwo-Yu Chuang, Adam S Olia, Tyler Stephens, I-Ting Teng, Yaroslav Tsybovsky, Tongqing Zhou, Vincent J Munster, David D Ho, Theodora Hatziioannou, Paul D Bieniasz, Michel C Nussenzweig, Peter D Kwong, Rafael Casellas
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature 595 (7866) (2021)
Bharat Madan, Eswar R Reddem, Pengfei Wang, Ryan G Casner, Manoj S Nair, Yaoxing Huang, Ahmed S Fahad, Matheus Oliveira de Souza, Bailey B Banach, Sheila N López Acevedo, Xiaoli Pan, Rajani Nimrania, I-Ting Teng, Fabiana Bahna, Tongqing Zhou, Baoshan Zhang, Michael T Yin, David D Ho, Peter D Kwong, Lawrence Shapiro, Brandon J DeKosky
Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS-CoV-2. AIChE journal. American Institute of Chemical Engineers 67 (12) (2021)
Gabriele Cerutti, Yicheng Guo, Pengfei Wang, Manoj S Nair, Yaoxing Huang, Jian Yu, Lihong Liu, Phinikoula S Katsamba, Fabiana Bahna, Eswar R Reddem, Peter D Kwong, David D Ho, Zizhang Sheng, Lawrence Shapiro
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain. bioRxiv : the preprint server for biology (2021)
Pengfei Wang, Lihong Liu, Manoj S Nair, Michael T Yin, Yang Luo, Qian Wang, Ting Yuan, Kanako Mori, Axel Guzman Solis, Masahiro Yamashita, Ankur Garg, Lawrence J Purpura, Justin C Laracy, Jian Yu, Leemor Joshua-Tor, Joseph Sodroski, Yaoxing Huang, David D Ho
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease. Emerging microbes & infections 9 (1) (2020)
Lihong Liu, Pengfei Wang, Manoj S Nair, Jian Yu, Micah Rapp, Qian Wang, Yang Luo, Jasper F-W Chan, Vincent Sahi, Amir Figueroa, Xinzheng V Guo, Gabriele Cerutti, Jude Bimela, Jason Gorman, Tongqing Zhou, Zhiwei Chen, Kwok-Yung Yuen, Peter D Kwong, Joseph G Sodroski, Michael T Yin, Zizhang Sheng, Yaoxing Huang, Lawrence Shapiro, David D Ho
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature 584 (7821) (2020)